Video Experimental Relacionado
Updated: Jul 13, 2026
10:28
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
La autoinhibición de la c-Abl
Helma Pluk1, Karel Dorey, Giulio Superti-Furga
1Developmental Biology Programme, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Cell
|February 8, 2002
Resumen
Los investigadores descubrieron que la c-Abl tirosina quinasa
Área de la Ciencia:
- Biología Molecular Biología Molecular
- La bioquímica es la bioquímica.
- Oncología Oncología.
Sus antecedentes:
- Los mecanismos moleculares precisos que rigen la actividad de la c-Abl tirosina quinasa han sido una pregunta de investigación de larga data.
- La desregulación de c-Abl está implicada en varios tipos de cáncer, particularmente la leucemia mieloide crónica a través de la proteína de fusión BCR-Abl.
Objetivo del estudio:
- Para dilucidar los mecanismos reguladores intrínsecos de la c-Abl tirosina quinasa.
- Para identificar los dominios específicos de proteínas responsables de la autorregulación del c-Abl.
- Comprender el papel de la regulación de c-Abl en la oncogénesis y la desregulación de BCR-Abl.
Principales métodos:
- En ensayos de actividad catalítica in vitro se utiliza la proteína c-Abl purificada.
- Análisis bioquímicos para investigar las interacciones proteína-proteína.
- Evaluación de las consecuencias funcionales de las modificaciones N-terminales en la actividad c-Abl.
Principales resultados:
- Se demostró que c-Abl posee capacidades inhibidoras intrínsecas, regulando su propia actividad catalítica.
- Identificó los residuos N-terminales 80 como un dominio "cap" crucial que media en la autorregulación.
- Se ha demostrado que la pérdida de este dominio de tapa N-terminal resulta en una transformación oncogénica y contribuye a la desregulación de BCR-Abl.
Conclusiones:
- La autorregulación es una propiedad inherente de la c-Abl tirosina quinasa, mediada por su dominio N-terminal.
- La tapa N-terminal es esencial para mantener la inhibición de c-Abl.
- La interrupción de este límite regulador es un evento clave en la activación oncogénica de c-Abl y la leucemogénesis relacionada con BCR-Abl.
Videos de Conceptos Relacionados
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...